Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEISA: H. pylori Eradication and Body Iron
NCT03146325Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Nov 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in Helicobacter pylori infection, sponsored by UTHealth Houston. Planned start Nov 2012; status: withdrawn.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03146325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146325.